CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 84 filers reported holding CRISPR THERAPEUTICS AG in Q4 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $17,000 | -32.0% | 225 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $25,000 | -30.6% | 225 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $36,000 | -58.6% | 225 | -68.7% | 0.00% | -60.0% |
Q1 2021 | $87,000 | -23.7% | 719 | -4.1% | 0.01% | -37.5% |
Q4 2020 | $114,000 | +83.9% | 750 | 0.0% | 0.01% | +60.0% |
Q3 2020 | $62,000 | -6.1% | 750 | -16.7% | 0.01% | -16.7% |
Q2 2020 | $66,000 | +247.4% | 900 | +100.0% | 0.01% | +200.0% |
Q1 2020 | $19,000 | -29.6% | 450 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $27,000 | +50.0% | 450 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $18,000 | -14.3% | 450 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $21,000 | +31.2% | 450 | 0.0% | 0.00% | +100.0% |
Q1 2019 | $16,000 | +6.7% | 450 | 0.0% | 0.00% | -50.0% |
Q4 2018 | $15,000 | -21.1% | 450 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $19,000 | -26.9% | 450 | 0.0% | 0.00% | -33.3% |
Q2 2018 | $26,000 | +30.0% | 450 | 0.0% | 0.00% | +50.0% |
Q1 2018 | $20,000 | +100.0% | 450 | 0.0% | 0.00% | +100.0% |
Q4 2017 | $10,000 | +25.0% | 450 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $8,000 | +14.3% | 450 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $7,000 | -22.2% | 450 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $9,000 | – | 450 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 3,608,874 | $160,053,562,000 | 54.44% |
Abingworth LLP | 1,237,202 | $54,858,000 | 32.62% |
NEA Management Company, LLC | 2,090,678 | $92,722,000 | 4.00% |
New Leaf Venture Partners, L.L.C. | 444,708 | $19,723,000 | 3.59% |
EcoR1 Capital, LLC | 500,000 | $22,175,000 | 2.00% |
ARK Investment Management | 1,453,590 | $64,467,000 | 1.95% |
CLOUGH CAPITAL PARTNERS L P | 337,731 | $14,978,000 | 1.41% |
Casdin Capital, LLC | 220,000 | $9,757,000 | 1.19% |
Valiant Capital Management, L.P. | 271,700 | $12,050,000 | 1.07% |
Monashee Investment Management LLC | 110,000 | $4,879,000 | 1.03% |